Spring direct naar de hoofdnavigatie of de inhoud

Dirk de Jong

Patent attorney

“Discovering the potential of your invention.”
Home / Experts / Dirk de Jong

Dirk de Jong

Dirk de Jong

  • Hightech & Electronics
  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate

Dirk de Jong started his career as a patent attorney in 1991 after having worked for Philips in research and development in the field of pattern recognition and image processing. He continued to work for Philips and its spin-out NXP as a patent attorney before joining V.O. in 2007.

More information about Dirk

As a physicist, Dirk has a broad focus on all aspects of high-tech, in particular informatics, signal processing, data processor designs, semiconductors, optics, lighting, thin film technology and mechatronics.

As a patent attorney Dirk has been involved in various IP-related activities including negotiations, patent revaluations and infringement cases, typically in the field of memory management and processor design.

Working experience

  • Patent Attorney, V.O. (2007-present)
  • NXP IP department (2006-2007)
  • Philips IP&S (1991-2006)
  • Philips Research (1985-1991)

Education

  • Certificate Natural Language Processing (2013, Online course Columbia University via Coursera.org)
  • Certificate Machine Learning (2012, Online course Stanford University)
  • Certificate Artificial Intelligence (2011, Online course Udacity)
  • MSc in Technical Physics, Delft University of Technology (1985), with specialization Signal Processing
  • BSc in Technical Physics, HTS Rijswijk (1978)

Publications

  • “Dutch Supreme Court again reviews Art. 69 EPC”, MIP International Briefing July-August 2012
  • “Court rejects Novartis injunction request”, MIP International Briefing September 2009
  • “Method for the perspective display of a part of a topographic map, and device suitable for performing such a method ” US5161886 (1992) and US5161886 (2001)
  • “Method of displaying navigation data …” US5115398 (1992)

Languages

  • English
  • Dutch

Also see these experts

Bart Jan Niestadt

Bart Jan Niestadt

  • European Patent Attorney
  • Dutch Patent Attorney
  • Belgian Patent Attorney
  • Senior Associate
Kasper Haak

Kasper Haak

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
More experts

News

HEMA faces claim by Levi’s over stitching

Denim giant Levi’s recently won a court case in Belgium against the well-known department store HEMA about the shape of the stitches on the rear of its jeans.Continue reading

Brexit

The impact of Brexit on IP rights

The United Kingdom is expected to leave the European Union on 29 March 2019, with or without a deal. The British Parliament has expressly stated that the existing IP rights that have been established within the EU context will be guaranteed in either case. Below you will find a brief overview of the impact on […]Continue reading

Supplier must warn of potential patent infringement in another country

Imagine that you sell a product that does not fall under the Netherlands’ patent protection to a customer, but your customer then exports the product to Germany where it is protected by a patent. How does this affect your liability?Continue reading

Events

Idea, IP & Innovation (3i-) Event

High Tech Campus Eindhoven, High Tech Campus, Eindhoven

On Tuesday 18 April TW.nl organizes the second edition of the 3i-Event. During this inspiring afternoon about Ideas, Intellectual property and Innovation on the Hightech Campus in Eindhoven, R&D professionals, startups and SME entrepreneurs will learn how to set up a successful IP strategy for their companies. More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event